Caxton Associates (New York)’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-11,491
| Closed | -$602K | – | 649 |
|
|
2024
Q3 | $602K | Buy |
+11,491
| New | +$602K | 0.02% | 336 |
|
|
2022
Q3 | – | Sell |
-151,213
| Closed | -$628K | – | 626 |
|
|
2022
Q2 | $628K | Buy |
151,213
+110,105
| +268% | +$457K | 0.06% | 204 |
|
|
2022
Q1 | $474K | Sell |
41,108
-18,289
| -31% | -$211K | 0.04% | 243 |
|
|
2021
Q4 | $593K | Buy |
+59,397
| New | +$593K | 0.06% | 210 |
|